Search details
1.
Clinical Application of Multimodal Sentinel Lymph Node Mapping Method in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy: An Interim Analysis.
Ann Surg Oncol
; 2024 May 08.
Article
in English
| MEDLINE | ID: mdl-38717546
2.
Final results of the randomized phase 2 LEO trial and bone protective effects of everolimus for premenopausal hormone receptor-positive, HER2-negative metastatic breast cancer.
Int J Cancer
; 2021 Apr 27.
Article
in English
| MEDLINE | ID: mdl-33905134
3.
Underutilisation of Physical Rehabilitation Therapy by Cancer Patients in Korea: a Population-based Study of 958,928 Korean Cancer Patients.
J Korean Med Sci
; 36(46): e304, 2021 Nov 29.
Article
in English
| MEDLINE | ID: mdl-34845872
4.
Genome-wide association study of genetic variants related to anthracycline-induced cardiotoxicity in early breast cancer.
Cancer Sci
; 111(7): 2579-2587, 2020 Jul.
Article
in English
| MEDLINE | ID: mdl-32378780
5.
Cumulative incidence of chemotherapy-induced cardiotoxicity during a 2-year follow-up period in breast cancer patients.
Breast Cancer Res Treat
; 182(2): 333-343, 2020 Jul.
Article
in English
| MEDLINE | ID: mdl-32468335
6.
Supervised Physical Rehabilitation in the Treatment of Patients with Advanced Cancer: a Systematic Review and Meta-analysis.
J Korean Med Sci
; 35(29): e242, 2020 Jul 27.
Article
in English
| MEDLINE | ID: mdl-32715671
7.
Randomised Phase 2 study of lapatinib and vinorelbine vs vinorelbine in patients with HER2 + metastatic breast cancer after lapatinib and trastuzumab treatment (KCSG BR11-16).
Br J Cancer
; 121(12): 985-990, 2019 12.
Article
in English
| MEDLINE | ID: mdl-31690831
8.
ASO Visual Abstract: Clinical Application of Multimodal Sentinel Lymph Node Mapping Method in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy: An Interim Analysis.
Ann Surg Oncol
; 2024 Jun 12.
Article
in English
| MEDLINE | ID: mdl-38864986
9.
The Sentinel Lymph Node Biopsy Using Indocyanine Green Fluorescence Plus Radioisotope Method Compared With the Radioisotope-Only Method for Breast Cancer Patients After Neoadjuvant Chemotherapy: A Prospective, Randomized, Open-Label, Single-Center Phase 2 Trial.
Ann Surg Oncol
; 26(8): 2409-2416, 2019 Aug.
Article
in English
| MEDLINE | ID: mdl-31065958
10.
Use of adjuvant chemotherapy in hormone receptor-positive breast cancer patients with or without the 21-gene expression assay.
Breast Cancer Res Treat
; 170(1): 69-76, 2018 Jul.
Article
in English
| MEDLINE | ID: mdl-29516374
11.
Novel JAK3-Activating Mutations in Extranodal NK/T-Cell Lymphoma, Nasal Type.
Am J Pathol
; 187(5): 980-986, 2017 May.
Article
in English
| MEDLINE | ID: mdl-28284718
12.
Comprehensive somatic genome alterations of urachal carcinoma.
J Med Genet
; 54(8): 572-578, 2017 08.
Article
in English
| MEDLINE | ID: mdl-28348108
13.
Clinical application of genomic profiling to find druggable targets for adolescent and young adult (AYA) cancer patients with metastasis.
BMC Cancer
; 16: 170, 2016 Feb 29.
Article
in English
| MEDLINE | ID: mdl-26925973
14.
P21 and CD166 as predictive markers of poor response and outcome after fluorouracil-based chemoradiotherapy for the patients with rectal cancer.
BMC Cancer
; 14: 241, 2014 Apr 04.
Article
in English
| MEDLINE | ID: mdl-24708484
15.
Regional disparities in the availability of cancer clinical trials in Korea.
Epidemiol Health
; 46: e2024006, 2024.
Article
in English
| MEDLINE | ID: mdl-38186251
16.
A 10-Gene Signature to Predict the Prognosis of Early-Stage Triple-Negative Breast Cancer.
Cancer Res Treat
; 2024 May 10.
Article
in English
| MEDLINE | ID: mdl-38754473
17.
A nationwide real-world study for evaluation of effectiveness and safety of T-DM1 in patients with HER2-positive metastatic breast cancer in Korea (KCSG BR19-15).
Ther Adv Med Oncol
; 16: 17588359231225029, 2024.
Article
in English
| MEDLINE | ID: mdl-38288157
18.
Surveillance of Symptom Burden Using the Patient-Reported Outcome Version of the Common Terminology Criteria for Adverse Events in Patients With Various Types of Cancers During Chemoradiation Therapy: Real-World Study.
JMIR Public Health Surveill
; 9: e44105, 2023 03 08.
Article
in English
| MEDLINE | ID: mdl-36884274
19.
Risk Factors for Palbociclib-Induced Early Developing Neutropenia in Patients with Hormone Receptor-Positive Metastatic Breast Cancer.
Cancers (Basel)
; 15(10)2023 May 18.
Article
in English
| MEDLINE | ID: mdl-37345147
20.
Androgen Receptor as a Predictive Marker for Pathologic Complete Response in Hormone Receptor-Positive and HER-2-Negative Breast Cancer with Neoadjuvant Chemotherapy.
Cancer Res Treat
; 55(2): 542-550, 2023 Apr.
Article
in English
| MEDLINE | ID: mdl-36097802